Suchergebnisse - "Luo, Donghan"

PubPharm (48)

1

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve (AMBER) and virologically suppressed (EMERALD) participants with neurological and/or psychiatric comorbidities : Week 96 subgroup analysis

enthalten in: HIV medicine | 2023

von Dunn, K. | Bushen, J. | Luo, D. | +3

2

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment‐naïve ( AMBER) and virologically suppressed ( EMERALD) participants with neurological and/or psychiatric comorbidities : Week 96 subgroup analysis

enthalten in: HIV Medicine | 2023

von Dunn, K. | Bushen, J. | Luo, D. | +3

3

Low Incidence and Brief Duration of Gastrointestinal Adverse Events with Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Over 96 Weeks : Post hoc Analyses of AMBER and EMERALD

enthalten in: Journal of the International Association of Providers of AIDS Care | 2022

von Dunn, K. | Baugh, B. | Bejou, N. | +4

4

METHODS OF TREATING SUBJECTS INFECTED WITH HIV

enthalten in: Europäisches Patentamt | 2021

von ANDERSON DAVID | CHOW WING | DUNN KEITH J | +3

5

A PROTEASE INHIBITOR REGIMEN FOR TREATING SUBJECTS INFECTED WITH HIV

enthalten in: Europäisches Patentamt | 2021

von ANDERSON DAVID | CHOW WING | DUNN KEITH | +3

6

Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection : a DIAMOND subgroup analysis

enthalten in: HIV research & clinical practice | 2021

von Dunn, K. | Rogers, R. | Simonson, R. | +5

7

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection : Primary Analysis of the DIAMOND Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Huhn, G. | Crofoot, G. | Ramgopal, M. | +7

8

Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus-infected patients : Long-term follow-up results from the open-label, Phase II IMPACT study

enthalten in: Health science reports | 2020

von Lawitz, E. | Poordad, F. | Gutierrez, J. | +8

9

Pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naïve and treatment-experienced patients with human immunodeficiency virus-1 infection

enthalten in: HIV research & clinical practice | 2020

von Lathouwers, E. | Seyedkazemi, S. | Luo, D. | +3

10

Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients : Long‐term follow‐up results from the open‐label, Phase II IMPACT study

enthalten in: Health Science Reports | 2020

von Lawitz, E. | Poordad, F. | Gutierrez, J. | +8

1
2
3
4
5
Nächster »
[5]